Ad
FBIO - Fortress Biotech Stock Trading
About | Fortress Biotech Inc. (NASDAQ:FBIO)
We are a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of inflammatory diseases and cancer.
Quote | Fortress Biotech Inc. (NASDAQ:FBIO)
| Last: | $0.3101 |
|---|---|
| Change Percent: | 1.67% |
| Open: | $0.3005 |
| Close: | $0.305 |
| High: | $0.3175 |
| Low: | $0.3 |
| Volume: | 31,872 |
| Last Trade Date Time: | 09/28/2023 03:00:00 am |
News | Fortress Biotech Inc. (NASDAQ:FBIO)
-
2023-09-27 14:04:27 ET More on Fortress Biotech Stocks To Watch: Investors Prep For Inflation Data And Q2 Earnings Rush Journey Medical announces exclusive license agreement with Maruho Journey Medical stock rallies 20% on Phase 3 studies update Seeking Alpha...
-
WALTHAM, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in a panel prese...
Message Board Posts | Fortress Biotech Inc. (NASDAQ:FBIO)
| Subject | By | Source | When |
|---|---|---|---|
| whytestocks: $FBIO News Article - Checkpoint Therapeutics Announces $6.1 Million Registered Direct O | whytestocks | investorshangout | 03/31/2023 5:40:56 PM |
| whytestocks: $FBIO News Article - Journey Medical Corporation Reports Full-Year 2022 Financial Resul | whytestocks | investorshangout | 03/29/2023 8:26:10 PM |
| whytestocks: $FBIO News Article - Journey Medical Corporation to Participate in the 35th Annual ROTH | whytestocks | investorshangout | 03/07/2023 6:35:47 PM |
| Has $FBIO gotten a NASDAQ warning letter yet? | Spicknspan | investorshub | 02/28/2023 12:20:02 AM |
| whytestocks: $FBIO News Article - Helocyte, Inc. Announces Positive Data from Stem Cell Transplant D | whytestocks | investorshangout | 02/16/2023 7:40:48 PM |
Fortress Biotech Inc. Company Name:
FBIO Stock Symbol:
NASDAQ Market:
Fortress Biotech Inc. Website:
Ad
-
The Dow Jones closed lower by around 69 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around...
-
WALTHAM, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage immunotherapy an...
-
WALTHAM, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in a panel prese...